Mechanisms of Injury - When Good Drugs Go Bad
- Intrinsic (Predictable): Dose-related, direct hepatocyte damage from a toxic metabolite.
- Classic example: Acetaminophen.
- Idiosyncratic (Unpredictable): Not dose-related; variable latency.
- Immune-mediated: Allergic features like fever, rash, eosinophilia (e.g., Halothane, Phenytoin).
- Non-immune: Metabolic abnormality (e.g., Isoniazid).

⭐ Acetaminophen overdose depletes glutathione (GSH), causing accumulation of the toxic metabolite NAPQI, which leads to centrilobular necrosis.
Patterns of Injury - Hepatocellular vs. Cholestatic
- Classification is based on the pattern of liver enzyme elevation. The R-value quantifies the type of injury:
- $R = (ALT / ULN_{ALT}) / (ALP / ULN_{ALP})$
| Pattern | R-Value | Primary Labs | Key Drug Culprits |
|---|---|---|---|
| Hepatocellular | >5 | ↑↑ ALT, AST | Acetaminophen, Isoniazid, Statins, NSAIDs |
| Cholestatic | <2 | ↑↑ ALP, GGT | Anabolic steroids, OCPs, Erythromycin |
| Mixed | 2-5 | ↑ ALT & ALP | Phenytoin, Carbamazepine, Sulfonamides |
⭐ Hy's Law: A key prognostic indicator for fatal DILI. It combines hepatocellular injury (jaundice with ↑ bilirubin) and significant ↑ aminotransferase levels, without initial cholestasis (normal ALP). This pattern signals a high risk of acute liver failure with >10% mortality.
Causative Agents - The Usual Suspects
-
Predictable (Intrinsic/Dose-Dependent):
- Acetaminophen: The classic example. Overdose depletes glutathione, leading to accumulation of toxic metabolite NAPQI and centrilobular necrosis.
-
Idiosyncratic (Unpredictable/Host-Dependent):
- Hepatocellular Pattern (↑↑ ALT):
- Anti-TB drugs (Isoniazid, Rifampin, Pyrazinamide)
- Antiepileptics (Valproate, Phenytoin)
- Statins, Ketoconazole, Halothane, Allopurinol
- Cholestatic Pattern (↑↑ ALP):
- Antibiotics (Amoxicillin-clavulanate, Erythromycin)
- Hormones (Anabolic steroids, Oral contraceptives)
- Antipsychotics (Chlorpromazine)
- Mixed Pattern:
- Carbamazepine, Phenytoin, Sulfonamides
- Hepatocellular Pattern (↑↑ ALT):
⭐ Amoxicillin-clavulanate is a leading cause of idiosyncratic DILI, typically presenting as cholestatic or mixed hepatitis. The injury can have a delayed onset of weeks to months after the drug is stopped.
Diagnosis & Management - Spotting & Stopping Toxins
- History is Key: Detailed review of all medications, supplements, & herbal products (timing is crucial).
- Pattern Recognition (R-Value):
- Calculate: $R = (\text{ALT} / \text{ULN}) / (\text{ALP} / \text{ULN})$
- Hepatocellular: $R \ge \textbf{5}$
- Cholestatic: $R \le \textbf{2}$
- Mixed: $R > \textbf{2}$ and $< \textbf{5}$

- Core Management:
- Discontinue the suspected offending agent immediately.
- Primarily supportive care.
- N-acetylcysteine (NAC) for acetaminophen toxicity.
- Consider liver biopsy if diagnosis is uncertain.
⭐ Amoxicillin-clavulanate is a classic cause of DILI, often presenting with a delayed cholestatic picture weeks after drug cessation.
High‑Yield Points - ⚡ Biggest Takeaways
- Acetaminophen toxicity is the most common cause of DILI; the antidote is N-acetylcysteine.
- DILI is classified as intrinsic (predictable, dose-related) or idiosyncratic (unpredictable).
- Centrilobular (Zone 3) necrosis is characteristic of injury from toxic metabolites, like with acetaminophen.
- Reye syndrome is a pediatric DILI caused by aspirin use during a viral infection.
- Key hepatotoxic drugs include anti-tuberculosis agents, amiodarone, methotrexate, and valproic acid.
- A thorough drug history is the most critical step in diagnosing DILI.
Unlock the full lesson and continue reading
Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more